WE ARE ENDECE
ENDECE, LLC is a privately held biopharmaceutical company focused on discovering and developing new drug therapies to stop or reverse disease progression by controlling key cellular pathways. These therapies exert their control over these pathways by targeting receptors within cell nuclei that regulate certain genes.
Our scientists invented compounds with potential benefit associated with novel mechanisms of action for treating multiple sclerosis (MS) and other neurological diseases. In addition to MS, we focus on diseases whose treatment options are limited or non-existent, whose causes may not be well understood and whose clinical development paths are still undefined.
ENDECE was founded in 2006 and is headquartered in Mequon, Wisconsin.
ENDECE Neural today announced plans to attend the 34th annual J.P. Morgan Healthcare Conference from January 11-14, 2016 at the Westin St. Francis Hotel in San Francisco, Calif.read more
BioPharm America 2015 James G. Yarger, Ph.D., ENDECE CEO, will be speaking at the BioPharm America conference to be held in Boston, Mass. from September 15-17, 2015.read more